Semi-Annual Statement Of Cash Flows

Delta-Fly Pharma, Inc. - Filing #7717381

Concept As at
2018-09-30
2018-04-01 to
2018-09-30
As at
2018-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-209,236,000 JPY
Interest paid
-175,000 JPY
Income taxes paid
-957,000 JPY
Net cash provided by (used in) operating activities
-247,429,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
JPY
Cash flows from financing activities
Repayments of long-term borrowings
-3,396,000 JPY
Net cash provided by (used in) financing activities
-5,396,000 JPY
Effect of exchange rate change on cash and cash equivalents
-11,000 JPY
Net increase (decrease) in cash and cash equivalents
-252,836,000 JPY
Cash and cash equivalents
528,414,000 JPY
781,250,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.